Endo Introduces New ADRENALIN® IV Bag Concentrations
Endo Expands Its ADRENALIN® Product Range
Endo has recently taken a significant step forward by launching new concentrations of its ADRENALIN® premixed intravenous (IV) bags. The new offerings include concentrations of 2 mg, 5 mg, and 10 mg per 250 mL, enhancing their existing lineup. This expansion marks a major achievement in providing healthcare professionals with ready-to-use solutions that streamline medication administration.
A Broader Array of Concentrations
The introduction of these additional concentrations brings the total number of available ADRENALIN® premixed IV bag options to five. Now healthcare providers can choose from 2 mg, 4 mg, 5 mg, 8 mg, and 10 mg concentrations. This variety ensures that physicians have access to various options tailored to the needs of their patients, improving the flexibility and effectiveness of treatment.
Support for Patient Safety Initiatives
The new 5 mg and 10 mg concentrations align with the American Society of Health-System Pharmacists (ASHP) Standardize 4 Safety Initiative. This initiative plays a critical role in enhancing patient safety and minimizing potential medication errors. By adhering to these recommended standards, Endo is actively contributing to the safety of medication administration in hospitals.
Key Advantages of ADRENALIN® Premixed IV Bags
Endo's ADRENALIN® premixed IV bags offer numerous benefits for healthcare facilities. One of the primary advantages is that there is no need for compounding or preparation by medical staff, which can often lead to errors or delays in treatment.
Efficient Workflow Support
The single-port IV tubing designed for these bags reduces the risks associated with inadvertent mixtures, enhancing safety during patient care. Furthermore, the 24-month shelf life at room temperature makes these bags practical and convenient for hospital pharmacies and emergency departments.
Support from Leadership
Scott Sims, Senior Vice President and General Manager of Endo Injectable Solutions and Generics, expressed enthusiasm about this product expansion. He stated, "We're proud to support hospital teams with ready-to-use medicines that help make care easier and more efficient. We're excited to grow our TruDelivery® portfolio and give providers more options to focus on what matters most–caring for patients." This commitment reflects Endo's dedication to improving healthcare delivery.
Indications and Usage
The ADRENALIN® premixed IV bag is indicated for use in increasing mean arterial blood pressure in adult patients experiencing hypotension associated with septic shock. Its formulation aims to provide effective intervention quickly, which is vital in critical care settings.
About Endo
Endo, a wholly owned subsidiary of Mallinckrodt plc, is dedicated to developing therapies that transform lives. The company's team collaborates passionately to create and deliver essential medications that provide hope and improve health outcomes for patients. With a focus on advancing healthcare, Endo remains at the forefront of innovation in therapeutic solutions.
Frequently Asked Questions
What is the new concentration range for ADRENALIN® IV bags?
The new concentrations for ADRENALIN® IV bags are 2 mg, 5 mg, and 10 mg per 250 mL, providing additional options for healthcare providers.
How does the ADRENALIN® product support patient safety?
The ADRENALIN® premixed IV bags align with the ASHP Standardize 4 Safety Initiative, which aims to reduce medication errors and enhance patient safety.
Who benefits from the ready-to-use ADRENALIN® products?
Healthcare providers in hospitals benefit from the ADRENALIN® products, allowing them to deliver medications efficiently without the need for preparation and compounding.
What is the shelf life of ADRENALIN® premixed IV bags?
ADRENALIN® premixed IV bags have a 24-month shelf life at room temperature, making them convenient for healthcare providers.
What indications are available for ADRENALIN® IV bags?
The ADRENALIN® IV bags are indicated to increase mean arterial blood pressure in adult patients suffering from hypotension associated with septic shock.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
